Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul N Durrington

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Current Opinion in Lipidology|August 9, 2022
Lipoprotein (a) in familial hypercholesterolaemiaPaul N Durrington, Bilal Bashir, Deepak Bhatnagar, et al.
Current Opinion in Lipidology|July 2, 2005
Cord blood lipoproteins and prenatal influencesNarinder Bansal, J Kennedy Cruickshank, Patrick McElduff, et al.
Current Opinion in Lipidology|July 1, 2014
Lipoprotein (a): gene geniePaul N Durrington, Jonathan D Schofield, Tarza Siahmansur, et al.
Current Opinion in Lipidology|June 24, 2015
How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personaeHandrean Soran, Jonathan D Schofield, Yifen Liu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 22, 2007
The robustness of the Roche 2nd generation homogenous HDL cholesterol (PEGME) method: assessment of the effect of serum sample storage for up to 8 years at -80 degrees CValentine Charlton-Menys, Yifen Liu, Ashley Moorhouse, et al.
Diabetes & Vascular Disease Research|April 25, 2019
The Reaven syndrome: An historical perspectiveHandrean Soran, Safwaan Adam, Jan H Ho, et al.
Current Opinion in Lipidology|June 21, 2019
Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemiaHandrean Soran, Jan H Ho, Safwaan Adam, et al.
Current Opinion in Lipidology|May 24, 2016
Diabetic dyslipidaemiaHandrean Soran, Jonathan D Schofield, Safwaan Adam, et al.
BMJ (Clinical Research Ed.)|July 27, 2002
Analysis of predicted coronary heart disease risk in England based on Framingham study risk appraisal models published in 1991 and 2000Kiran Nanchahal, John R Duncan, Paul N Durrington, et al.
Diabetes Research and Clinical Practice|April 6, 2004
Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemiaPaul N Durrington, Jaakko Tuomilehto, Andreas Hamann, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Current Opinion in Lipidology|August 9, 2022
Lipoprotein (a) in familial hypercholesterolaemiaPaul N Durrington, Bilal Bashir, Deepak Bhatnagar, et al.
Current Opinion in Lipidology|July 2, 2005
Cord blood lipoproteins and prenatal influencesNarinder Bansal, J Kennedy Cruickshank, Patrick McElduff, et al.
Current Opinion in Lipidology|July 1, 2014
Lipoprotein (a): gene geniePaul N Durrington, Jonathan D Schofield, Tarza Siahmansur, et al.
Current Opinion in Lipidology|June 24, 2015
How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personaeHandrean Soran, Jonathan D Schofield, Yifen Liu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 22, 2007
The robustness of the Roche 2nd generation homogenous HDL cholesterol (PEGME) method: assessment of the effect of serum sample storage for up to 8 years at -80 degrees CValentine Charlton-Menys, Yifen Liu, Ashley Moorhouse, et al.
Diabetes & Vascular Disease Research|April 25, 2019
The Reaven syndrome: An historical perspectiveHandrean Soran, Safwaan Adam, Jan H Ho, et al.
Current Opinion in Lipidology|June 21, 2019
Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemiaHandrean Soran, Jan H Ho, Safwaan Adam, et al.
Current Opinion in Lipidology|May 24, 2016
Diabetic dyslipidaemiaHandrean Soran, Jonathan D Schofield, Safwaan Adam, et al.
BMJ (Clinical Research Ed.)|July 27, 2002
Analysis of predicted coronary heart disease risk in England based on Framingham study risk appraisal models published in 1991 and 2000Kiran Nanchahal, John R Duncan, Paul N Durrington, et al.
Diabetes Research and Clinical Practice|April 6, 2004
Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemiaPaul N Durrington, Jaakko Tuomilehto, Andreas Hamann, et al.
Pageof 11